Regulator acts to close loophole enabling Australian pharmacists to make copycat Ozempic drug Thu 29 Feb 2024 at 7:06pm , updated Fri 1 Mar 2024 at 4:06pm The Therapeutic Goods Administration (TGA) will move to ban compounding pharmacists from making their own versions of injectable weight loss drugs due to concerns the compounded products may not be safe or effective
Because of the unknown potential for serious adverse reactions in the breastfed infant due to the possible accumulation of SNAC from breastfeeding and because semaglutide injection can be considered for use during lactation, advise patients that breastfeeding is not recommended during treatment with oral semaglutide tablets
The transition typically involves: Matching equivalent doses between formulations and medications Monitoring blood sugar levels during the switch Maintaining consistent injection schedules Your provider might recommend evidence-based nutrition counseling or programs to support your transition and maximize results
Pricing: $300/month in 3-month plans
Tirzepatide, sold under the brand name Mounjaro (for diabetes) and Zepbound (for weight loss), is a newer medication that targets two hormones instead of just one
Body image improvement follows weight loss but often lags behind
